Investor-only Dinner

Wednesday 1st April 2009 - BioTrinity 2009 - Oxford
19:30-23:00

Investor-only Dinner This invitation-only 6 course wine and tasting dinner will give investors the chance to get together and network in an exclusive environment, afterwards to be whisked back to their hotels by carriages, ready for the first day of the BioTrinity Conference.

A select group of qualified active life science investors have been invited to attend the BioTrinity Investor-Only Dinner, a gathering that one invitee has referred to as the BioTrinity international "VC Hall of Fame". This dinner provides a forum for closer working relationships to be developed and to encourage co-participation on future investment rounds in the UK life science sector on the eve of UK’s premier biotechnology and investment conference.

This event is kindly sponsored and hosted by Technomark Life Sciences.

Investors will join us for cocktails and an outstanding tasting menu with each course being accompanied by a selection of an American and a French wine. The evening will come to a close with a single malt tasting from a private collection. Complimentary carriages will be provided for those guests having Oxford-area destinations.

Confirmations have already been received from the following, and the list of acceptances is growing rapidly:

Atlas Venture MVM Life Science Partners
Genzyme Ventures (US) Avlar BioVentures
Abingworth SR One
TRI Inc. (US) Novo A/S (Denmark)
Ipso Ventures Oxford Technology Management
Andy Richards H20 Venture Partners
London Technology Fund Esperante Ventures (Netherlands)
SPARK Ventures Excalibur (formerly Merlin Biosciences)
ETV Capital Edmond de Rothschild Investment Partners (France)
Orion Healthcare Equity Partners (US) BSI SA(Italy)
Oxford Capital Partners Rainbow Seed Fund
Mercia Technology Seed Fund Nomura Code Securities
Forbion Capital Partners Canaccord Adams
Rosetta Capital Advent Venture Partners
Seraphim Capital Louis Nisbet
IP Group plc IQ Capital
Entrepreneurs Fund Sofinnova Ventures
JP Morgan Beringea


PROJECT PARTNERS

Scrip Project Partner: BioSpectrumAsia Project Partner: PharmaLicensing
Project Partner: London Biotechnology Network Project Partner: Thames Valley Life Science Network EBN
Project Partner: Biotech-Finances.com Drug Discovery Today covers not only drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed - Supporting Partners to BioTrinity MedNous

Register online now!


 


  Hosted by:
Technomark Life Sciences - Host of the Investor Dinner